Squamous cell skin cancer (just a small spelling note there!) developing alongside myeloma is not uncommon. Myeloma weakens the immune system, which raises the risk of skin tumors — both cancerous and non-cancerous.
Some myeloma treatments can also contribute to this risk. For example, Revlimid (lenalidomide), which is Show Full Answer
Squamous cell skin cancer (just a small spelling note there!) developing alongside myeloma is not uncommon. Myeloma weakens the immune system, which raises the risk of skin tumors — both cancerous and non-cancerous.
Some myeloma treatments can also contribute to this risk. For example, Revlimid (lenalidomide), which is part of the DVRd regimen, has been associated with an increased risk of skin cancers. Members of MyMyelomaTeam have shared similar experiences. One MyMyelomaTeam member noted they had been dealing with basal and squamous cell skin cancers since 2002, getting checked every six months with something always being found. Another mentioned getting skin biopsies done after being told Revlimid can cause skin cancer.
Here are some important steps to keep in mind:
- Tell your oncologist right away so they can coordinate care with a dermatologist
- Get regular skin checks — every six months is common practice for myeloma patients
- Catch it early — squamous cell skin cancer is very treatable when found early
- Don't stop your myeloma treatment without consulting your care team first
It's a lot to deal with on top of everything else, but you're not alone in this. Make sure your medical team knows so they can help manage both conditions together.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Rashes and Skin Changes With Myeloma
August 7
Join
Your Privacy Choices
